(Q39077347)

8 September 2017

In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections (English)

1 reference

8 September 2017

Ellie J. C. Goldstein

series ordinal

1

object named as

Ellie J C Goldstein

1 reference

8 September 2017

5

Kerin L Tyrrell

1 reference

8 September 2017

2

Diane M Citron

1 reference

8 September 2017

3

C Vreni Merriam

1 reference

8 September 2017

4

Yumi A Warren

1 reference

8 September 2017

Helen T Fernandez

6

1 reference

PMC publication ID

1635191

8 September 2017

language of work or name

English

0 references

publication date

18 September 2006

1 reference

Antimicrobial Agents and Chemotherapy

8 September 2017

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

8 September 2017

50

1 reference

8 September 2017

11

1 reference

8 September 2017

3959-3962

1 reference

In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci

8 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635191

In vitro activities of BAL9141, a novel broad-spectrum pyrrolidinone cephalosporin, against gram-negative nonfermenters

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635191

Foot infections in diabetic patients: the role of anaerobes

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635191

Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635191

Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635191

In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635191

BAL 9141, a new broad-spectrum pyrrolidinone cephalosporin: activity against clinically significant anaerobes in comparison with 10 other antimicrobials

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635191

Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1635191

Patterns of foot examination in a diabetes clinic

21 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16982780

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00722-06

1 reference

8 September 2017

1 reference

PMC publication ID

1635191

8 September 2017

PubMed publication ID

16982780

1 reference

PMC publication ID

1635191